• Home
  • Search Results
  • Synthesis of mesoporous MFI zeolite via bacterial cellulose-derived carbon templating for fast adsorption of formaldehyde.

Synthesis of mesoporous MFI zeolite via bacterial cellulose-derived carbon templating for fast adsorption of formaldehyde.

Journal of hazardous materials (2019-10-21)
Arnon Khamkeaw, Muenduen Phisalaphong, Bunjerd Jongsomjit, Kun-Yi Andrew Lin, Alex C K Yip
ABSTRACT

Mesoporous ZSM-5 (MFI) zeolite was synthesized by using bacterial cellulose-derived activated carbon (BC-AC500) with a high surface area as a hard template. Different ratios of BC-AC500 and zeolite precursor gel were prepared in a Teflon-lined autoclave and crystallized at 180 °C for 48 h in a rotating oven. The physicochemical properties of the samples were characterized by x-ray diffraction (XRD), scanning/transmission electron microscopies (SEM/TEM), and N2 physisorption techniques. It was found that the mesoporous ZSM-5 zeolites have a specific surface area of 184-190 m2/g, a high mesopore volume of 0.120-0.956 ml/g and a wide pore size distribution ranging from 5 to 100 nm with a maximum at approximately 25.3 nm. The successfully made mesoporous ZSM-5 was tested as an adsorbent for formaldehyde adsorption in batch mode. The mesoporous ZSM-5 zeolite made from bacterial cellulose-derived activated carbon showed significantly faster adsorption kinetics than conventional ZSM-5 (0.0081 vs. 0.0007 g/mg min, respectively). The prepared material has an adsorption capacity of 98 mg/g and is highly reusable. The reported mesoporous ZSM-5 zeolites can be deployed for the rapid removal of toxic organics from wastewater when urgently needed, e.g., under breakthrough conditions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Aluminum isopropoxide, ≥98%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.